An unclear partnership: What has to change to enable better collaboration?
What has to change for physicians and APPs to work better together?
An unclear partnership: What is the patient perspective on APP and physician collaboration?
What is the patient perspective on APPs and physicians and how should it influence future changes?
An unclear partnership: How payment models affect APP-physician collaboration
How payment models affect APP-physician collaboration
An unclear partnership: How do we get physicians and APPs to work together better?
How do we get physicians and APPs to work together better?
An unclear partnership: The lack of clarity on the role of APPs
The lack of clarity around the role of APPs can create workplace friction
An unclear partnership: The key research findings about physician-APP collaboration
What the latest research says about physician and APP collaboration
An unclear partnership: Collaboration between physicians and APPs in primary care
What is the role of the advanced practice provider compared to a physician in primary care?
Medicare Drug Price Negotiations: Who really benefits?
Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.
Drug prices: Medicare coverage of antiobesity medications
A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.
Drug prices: Additional provisions to help beneficiaries
Drug prices: Real benefits for seniors in the Inflation Reduction Act
Drug prices: Utilization management with insurance and patients
Drug prices: Formulary inclusion vs. formulary placement
Drug prices: Expensive, but for whom?
Drug prices: Another way to interpret negotiations for cost
Drug prices: Introducing research and patient advocacy group AAR
The ransomware threat: How it's changing and what you can do about it
Everything you need to know about the rapidly changing cyberthreat - and what you can do to protect your practice from cybercriminals
The ransomware threat: Phishing and trends in cyber threats
Phishing is still a major access method to a medical practice - and trends in ransomware are changing
The ransomware threat: Health care is a prime target - what can a practice do to protect itself?
Will health care continue to be a prime target in 2025? And what can a practice do to protect itself from these sophisticated cybercriminals?
The ransomware threat: Where the gangs operate and how they find you
Ransomware groups primarily operate from a few countries, and how they find a small medical practice to attack might surprise you.
The ransomware threat: Why law enforcement struggles to stop cyber gangs
If cybercriminals are part of larger organizations, why can't law enforcement find and stop them?
The ransomware threat: Why cybercriminals are demanding immediate payments
Cybercriminals are not allowing time for organizations to make a decision on whether to pay the ransom or not
The ransomware threat: Would banning payments stop ransomware attacks?
If the government banned paying ransoms to cybercriminals, would it stop the attacks?
The ransomware threat: How many splinter groups are out there threatening your practice?
Affiliate splinter groups are numerous and pose a rising threat
The ransomware threat: How the "affiliate" trend threatens your practice
Affiliates who work for larger cybercriminal organizations are increasing the threat to medical practices
AMR: Responsibilities of other clinicians
An infectious disease expert describes the state of AMR – and how to fight it.
The ransomware threat: Why a surge in health care attacks happened in 2024
Ransomware gangs are increasingly targeting small medical practices
AMR: Policies and practices that could combat antimicrobial resistance
AMR: Antimicrobial resistance at the patient level
AMR: Antimicrobial resistance in the environment and animals
